Lot-to-Lot Consistency, Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (Split Virion), Inactivated (IIV4) in Healthy Population Aged 9-59 Years: A Randomized, Double-Blind, Controlled, Phase Ⅳ Clinical Trial
crossref（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要